Y-20811 (sodium)

Y-20811 sodium is a selective and orally active thromboxane synthetase inhibitor. Y-20811 sodium can irreversibly inhibit thromboxane (TX) A2 synthesis. Y-20811 sodium can be used for the research of cardiovascular disease, such as thrombosis[1].

Product Specifications

CAS Number

[104363-98-6]

UNSPSC

12352005

Target

Prostaglandin Receptor

Related Pathways

GPCR/G Protein

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Smiles

O=C(C1=CC(C)=C(C(C2=CC(N3C=NC=C3)=CC=C2C)O)C(C)=C1)O[Na]

Molecular Formula

C20H19N2NaO3

Molecular Weight

358.37

References & Citations

[1]Mikashima H, et al. Irreversible inhibition of thromboxane (TX) A2 synthesis by Y-20811, a selective TX synthetase inhibitor. Biochem Pharmacol. 1992 Jan 22;43 (2) :295-9.